Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Agilent Technologies's Enterprise Value is $41,165 Mil.
Agilent Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $1,424 Mil. Therefore, Agilent Technologies's EV-to-EBIT ratio for today is 28.91.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Agilent Technologies's Enterprise Value is $41,165 Mil.
Agilent Technologies's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $1,690 Mil. Therefore, Agilent Technologies's EV-to-EBITDA ratio for today is 24.36.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Agilent Technologies's Enterprise Value is $41,165 Mil.
Agilent Technologies's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was $6,735 Mil. Therefore, Agilent Technologies's EV-to-Revenue ratio for today is 6.11.
Agilent Technologies Enterprise Value Historical Data
The historical data trend for Agilent Technologies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Agilent Technologies's Enterprise Value
For the Diagnostics & Research subindustry, Agilent Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Enterprise Value falls into.
Agilent Technologies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Agilent Technologies's Enterprise Value for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (NYSE:A) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Agilent Technologies's current Enterprise Value is $41,165 Mil.
Agilent Technologies's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,424 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Agilent Technologies's current Enterprise Value is $41,165 Mil.
Agilent Technologies's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,690 Mil.
Agilent Technologies's current Enterprise Value is $41,165 Mil.
Agilent Technologies's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,735 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies Enterprise Value Related Terms
Thank you for viewing the detailed overview of Agilent Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Agilent Technologies (Agilent Technologies) Business Description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
A has been successfully added to your 